Lundbeck appoints VP of global pricing and market access Lundbeck appoints VP of global pricing and market access Plans launch of three products this year Andrea Rappagliosi becomes president of Vaccines Europe Andrea Rappagliosi becomes president of Vaccines Europe He is VP of Market Access, Health Policy & Medical Affairs at Sanofi Pasteur MSD Tim Mayleben rejoins Esperion as president and CEO Tim Mayleben rejoins Esperion as president and CEO Founder Roger Newton will become chairman and CSO Bayer names Early Excellence in Science prize winners Bayer names Early Excellence in Science prize winners Three young scientists are awarded €10,000 each SCM strengthens quality team SCM strengthens quality team Appoints Mark Edwards as Quality Assurance director AMRI promotes Richard Saffee to VP and general manager of large-scale manufacturing AMRI promotes Richard Saffee to VP and general manager of large-scale manufacturing Will drive synergies between locations in India, the UK and the US Sanofi appoints chairman of SDSAC Sanofi appoints chairman of SDSAC Dr Gary Nabel succeeds Dr Richard Klausner Cell Therapy Catapult makes three senior appointments Cell Therapy Catapult makes three senior appointments Focused on the development of the UK cell therapy industry Dow CEO wins 2013 SCI Chemical Industry Medal Dow CEO wins 2013 SCI Chemical Industry Medal Andrew Liveris is 6th Dow leader to receive the Medal since 1933 Sanofi president of Global Operations to retire mid-2013 Sanofi president of Global Operations to retire mid-2013 Hanspeter Spek joined the company in 1985 Amgen makes changes to board Amgen makes changes to board They will come into effect on 1 January 2013 Victrex team goes the distance for charity Victrex team goes the distance for charity Peak District hike raises funds for The Christie in Manchester Dr Rabinder Buttar wins Scottish Asian Business Award Dr Rabinder Buttar wins Scottish Asian Business Award ClinTec sees 15th year of continued growth Michael Koenig appointed to Bayer board of management Michael Koenig appointed to Bayer board of management Dr Richard Pott to retire, effective 1 June 2013 Sygnature Discovery appoints VP of Business Development – North America Sygnature Discovery appoints VP of Business Development – North America Plans to expand customer base in the US and Canada over next two years Charlie Morris joins Almac’s clinical technologies team Charlie Morris joins Almac’s clinical technologies team Will oversee development of IXRS technology